FDA Inspection 1096452 — Fujirebio Europe N.V.
The FDA completed an inspection of Fujirebio Europe N.V. on June 6, 2019 in Gent. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 6, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Gent (Belgium)
Additional Details
Postmarket Audit Inspections